scholarly journals Summary of Proceedings and Expert Consensus Statements From the International Summit “Lipids in Parenteral Nutrition”

2020 ◽  
Vol 44 (S1) ◽  
Author(s):  
Robert G. Martindale ◽  
David Berlana ◽  
Joseph I. Boullata ◽  
Wei Cai ◽  
Philip C. Calder ◽  
...  
2021 ◽  
Vol 78 (2) ◽  
pp. 117-128
Author(s):  
Yoo Jin Lee ◽  
Seong-Eun Kim ◽  
Yong Eun Park ◽  
Ji Young Chang ◽  
Hyun Joo Song ◽  
...  

2018 ◽  
Vol 65 ◽  
pp. 17-23 ◽  
Author(s):  
María Julia Ocón Bretón ◽  
Luis Miguel Luengo Pérez ◽  
Juan Antonio Virizuela ◽  
Julia Álvarez Hernández ◽  
Paula Jiménez Fonseca ◽  
...  

Author(s):  
Luigi Vetrugno ◽  
Francesco Mojoli ◽  
Andrea Cortegiani ◽  
Elena Giovanna Bignami ◽  
Mariachiara Ippolito ◽  
...  

Abstract Background To produce statements based on the available evidence and an expert consensus (as members of the Lung Ultrasound Working Group of the Italian Society of Analgesia, Anesthesia, Resuscitation, and Intensive Care, SIAARTI) on the use of lung ultrasound for the management of patients with COVID-19 admitted to the intensive care unit. Methods A modified Delphi method was applied by a panel of anesthesiologists and intensive care physicians expert in the use of lung ultrasound in COVID-19 intensive critically ill patients to reach a consensus on ten clinical questions concerning the role of lung ultrasound in the following: COVID-19 diagnosis and monitoring (with and without invasive mechanical ventilation), positive end expiratory pressure titration, the use of prone position, the early diagnosis of pneumothorax- or ventilator-associated pneumonia, the process of weaning from invasive mechanical ventilation, and the need for radiologic chest imaging. Results A total of 20 statements were produced by the panel. Agreement was reached on 18 out of 20 statements (scoring 7–9; “appropriate”) in the first round of voting, while 2 statements required a second round for agreement to be reached. At the end of the two Delphi rounds, the median score for the 20 statements was 8.5 [IQR 8.9], and the agreement percentage was 100%. Conclusion The Lung Ultrasound Working Group of the Italian Society of Analgesia, Anesthesia, Resuscitation, and Intensive Care produced 20 consensus statements on the use of lung ultrasound in COVID-19 patients admitted to the ICU. This expert consensus strongly suggests integrating lung ultrasound findings in the clinical management of critically ill COVID-19 patients.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Seyhmus Kavak ◽  
Recai Duymus

Abstract Background This study aimed to compare the performance and interobservers agreement of cases with findings on chest CT based on the British Society of Thoracic Imaging (BSTI) guideline statement of COVID-19 and the Radiological Society of North America (RSNA) expert consensus statement. Methods In this study, 903 patients who had admitted to the emergency department with a pre-diagnosis of COVID-19 between 1 and 18 July 2020 and had chest CT. Two radiologists classified the chest CT findings according to the RSNA and BSTI consensus statements. The performance, sensitivity and specificity values of the two classification systems were calculated and the agreement between the observers was compared by using kappa analysis. Results Considering RT-PCR test result as a gold standard, the sensitivity, specificity and positive predictive values were significantly higher for the two observers according to the BSTI guidance statement and the RSNA expert consensus statement (83.3%, 89.7%, 89.0%; % 81.2,% 89.7,% 88.7, respectively). There was a good agreement in the PCR positive group (κ: 0.707; p < 0.001 for BSTI and κ: 0.716; p < 0.001 for RSNA), a good agreement in the PCR negative group (κ: 0.645; p < 0.001 for BSTI and κ: 0.743; p < 0.001 for RSNA) according to the BSTI and RSNA classification between the two radiologists. Conclusion As a result, RSNA and BSTI statement provided reasonable performance and interobservers agreement in reporting CT findings of COVID-19. However, the number of patients defined as false negative and indeterminate in both classification systems is at a level that cannot be neglected.


2019 ◽  
Vol 11 (1) ◽  
pp. E19-E19
Author(s):  
Fernando Alfonso ◽  
Marcos García-Guimaraes ◽  
Teresa Bastante ◽  
Francisco de la Cuerda ◽  
Paula Antuña ◽  
...  

2017 ◽  
Vol 40 (3) ◽  
pp. 177-185
Author(s):  
Susie Sennhauser ◽  
Rishi Anand ◽  
Fred Kusumoto ◽  
Nora Goldschlager

2014 ◽  
Vol 22 ◽  
pp. 43 ◽  
Author(s):  
C.E. Simmons ◽  
S. Hogeveen ◽  
R. Leonard ◽  
Y. Rajmohan ◽  
D. Han ◽  
...  

BackgroundUse of the neoadjuvant approach to treat breast cancer patients has increased since the early 2000s, but the overall pathway of care for such patients can be highly variable. The aim of our project was to establish a multidisciplinary consensus among clinicians with expertise in neoadjuvant therapy (nat) for breast cancer and to determine if that consensus reflects published methods used in randomized controlled trials (rcts) in this area.MethodsA modified Delphi protocol, which used iterative surveys administered to 85 experts across Canada, was established to obtain expert consensus concerning all aspects of the care pathway for patients undergoing nat for breast cancer. All rcts published between January 1, 1967, and December 1, 2012, were systematically reviewed. Data extracted from the rcts were analyzed to determine if the methods used matched the expert consensus for specific areas of nat management. A scoring system determined the strength of the agreement between the literature and the expert consensus.ResultsConsensus was achieved for all areas of the pathway of care for patients undergoing nat for breast cancer, with the exception of the role of magnetic resonance imaging in the pre-treatment or preoperative setting. The levels of agreement between the consensus statements and the published rcts varied, primarily because specific aspects of the pathway of care were not well described in the reviewed literature.ConclusionsA true consensus of expert opinion concerning the pathway of care appropriate for patients receiving nat for breast cancer has been achieved. A review of the literature illuminated gaps in the evidence about some elements of nat management. Where evidence is available, agreement with expert opinion is strong overall. Our study is unique in its approach to establishing consensus among medical experts in this field and has established a pathway of care that can be applied in practice for patients receiving nat.


Sign in / Sign up

Export Citation Format

Share Document